ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

JAMES MCGOWAN M.D.

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,306Medicare Part D Prescriptions Filled, Including Refills

Rank: 50 out of 1456

$1.22M Total Retail Price of All Prescriptions

Rank: 68 out of 1456

690 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
70% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 690 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

13% of this provider’s 690 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

3% of this provider’s 20,538 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
AMLODIPINE BESYLATE 1,026 878 1 1
FUROSEMIDE 789 700 2 7
LISINOPRIL 767 638 3 3
METOPROLOL TARTRATE 732 649 4 12
LEVOTHYROXINE SODIUM 689 616 5 4
WARFARIN SODIUM 620 547 6 21
SIMVASTATIN 599 548 7 2
POTASSIUM CHLORIDE 589 504 8 15
OMEPRAZOLE 566 467 9 5
HYDROCHLOROTHIAZIDE 456 389 10 10
TRAMADOL HCL 374 345 11 17
CARVEDILOL 374 355 11 20
DONEPEZIL HCL 339 339 13 29
METFORMIN HCL 338 240 14 8
HYDROCODONE-ACETAMINOPHEN 324 281 S3 15 6
GABAPENTIN 286 241 16 13
NAMENDA 265 265 17 38
FAMOTIDINE 263 223 18 45
CITALOPRAM HBR 260 221 19 22
ATORVASTATIN CALCIUM 260 238 19 11
TAMSULOSIN HCL 254 253 21 34
METOPROLOL SUCCINATE 252 235 22 19
PRAVASTATIN SODIUM 247 202 23 9
NEXIUM 246 179 24 23
LANTUS 240 196 25 50
MELOXICAM 226 164 26 30
NOVOLOG 221 174 27 104
METFORMIN HCL ER 220 167 28 54
GLIPIZIDE 196 157 29 53
SERTRALINE HCL 176 106 30 25
HYDRALAZINE HCL 174 137 31 48
SEROQUEL 173 159 32 154
CLONIDINE HCL 166 101 33 39
LOSARTAN POTASSIUM 161 144 34 16
RANITIDINE HCL 151 122 35 27
ZOLPIDEM TARTRATE 150 116 36 14
AMLODIPINE BESYLATE-BENAZEPRIL 145 112 37 61
SULFAMETHOXAZOLE-TRIMETHOPRIM 145 112 37 107
ALLOPURINOL 144 130 39 31
LISINOPRIL-HYDROCHLOROTHIAZIDE 143 99 40 24
CLOPIDOGREL 142 138 41 32
ATENOLOL 142 142 41 18
RISPERIDONE 141 117 43 72
EXELON 140 140 44 105
ACTOS 136 135 45 115
FLUOXETINE HCL 125 102 46 55
GLIMEPIRIDE 119 65 47 33
PLAVIX 115 106 48 46
ALENDRONATE SODIUM 114 106 49 36
ZETIA 109 92 50 71
CELEBREX 108 85 51 88
LOSARTAN-HYDROCHLOROTHIAZIDE 102 92 52 41
MIRTAZAPINE 102 93 52 65
ADVAIR DISKUS 100 80 54 63
PHENYTOIN SODIUM EXTENDED 98 68 55 128
RAMIPRIL 96 96 56 98
PAROXETINE HCL 95 95 57 67
SYNTHROID 95 72 57 37
DIVALPROEX SODIUM 87 62 59 108
KLOR-CON M20 87 72 59 51
QUETIAPINE FUMARATE 87 65 59 78
AZITHROMYCIN 80 56 62 44
HYDROXYZINE HCL 79 64 R 63 164
MECLIZINE HCL 79 76 63 101
ISOSORBIDE MONONITRATE ER 79 79 63 60
PROMETHAZINE HCL 77 64 R 66 77
METOCLOPRAMIDE HCL 76 43 67 125
GLIPIZIDE ER 75 64 68 86
GLIPIZIDE XL 74 65 69 134
BISOPROLOL FUMARATE 74 63 69 208
SPIRIVA 72 68 71 75
NOVOLIN 70-30 72 72 71 144
LEVETIRACETAM 71 68 73 97
BENAZEPRIL HCL 71 57 73 57
CYMBALTA 69 37 75 52
LEVOFLOXACIN 69 61 75 79
HUMULIN 70-30 69 48 75 205
CEPHALEXIN 68 65 78 123
ONGLYZA 68 52 78 202
AMIODARONE HCL 67 67 80 228
FLUTICASONE PROPIONATE 67 56 80 28
GLYBURIDE-METFORMIN HCL 67 48 R 80 119
GALANTAMINE HBR 67 67 80 309
DIOVAN 66 52 84 35
SPIRONOLACTONE 66 66 84 73
TRICOR 66 52 84 92
THEOPHYLLINE ANHYDROUS 65 65 87 238
QUINAPRIL HCL 64 42 88 155
GLYBURIDE 63 63 R 89 94
ENALAPRIL MALEATE 62 62 90 87
LOVASTATIN 62 49 90 40
LIPITOR 62 60 90 76
BACLOFEN 62 17 90 168
OXYBUTYNIN CHLORIDE 61 53 94 156
FENTANYL 61 38 S2 94 114
DILTIAZEM 24HR ER 60 42 96 126
SINGULAIR 60 43 96 83
OLANZAPINE 60 53 96 183
DIOVAN HCT 59 48 99 59
NITROFURANTOIN 59 45 99 417
DETROL LA 58 45 101 213
OXYBUTYNIN CHLORIDE ER 57 57 102 167
VERAPAMIL ER 57 45 102 82
BUSPIRONE HCL 57 53 102 151
PROAIR HFA 56 23 105 69
TRAZODONE HCL 55 55 106 47
DIGOXIN 54 54 107 62
LYRICA 54 40 107 91
INSULIN SYRINGE 54 34 107 64
POLYETHYLENE GLYCOL 3350 53 44 110 85
AMOXICILLIN 53 36 110 112
IBUPROFEN 53 34 110 103
KLOR-CON 10 53 48 110 96
PREDNISONE 52 40 114 42
PREMARIN 52 40 R 114 99
PROPRANOLOL HCL 51 34 116 143
TERAZOSIN HCL 51 36 116 142
BENICAR 51 40 116 130
VENLAFAXINE HCL ER 50 49 119 89
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.